Viewing Study NCT00368251

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:54 PM
Ignite Modification Date: 2026-01-29 @ 7:29 PM
Study NCT ID: NCT00368251
Status: COMPLETED
Last Update Posted: 2023-05-31
First Post: 2006-08-23
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Brivaracetam as add-on Treatment of Unverricht-Lundborg Disease (ULD) in Adolescents and Adults
Sponsor: UCB Pharma
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Unverricht-Lundborg Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Unverricht-Lundborg Disease View
None Baltic Myoclonus View
None Progressive Myoclonic Epilepsies View
None Myoclonus View
None Brivaracetam View